Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2

Pediatric, adolescent and young adult (AYA) patients receiving novel cancer immunotherapies may develop associated toxicities with overlapping signs and symptoms that are not always easily distinguished from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection/clinical sequelae. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragoonanan, Dristhi, Khazal, Sajad J., Mejia, Rodrigo, Ewing, Linette, Durand, Jean-Bernard, Bashoura, Lara, Tayar, Jean, Dailey Garnes, Natalie, Petropoulos, Demetrios, Tewari, Priti, Bhatti, Micah, Ahmad, Ali Haider, Cortes, Jose, Razvi, Shehla, McBeth, Katrina, Swinford, Rita, Shoberu, Basirat, Waseemuddin, Waseem, Chi, Linda, Gill, Jonathan B., Zaky, Wafik, Daw, Najat, Gutierrez, Cristina, Tereffe, Welela, Kebriaei, Partow, Rezvani, Katayoun, Shpall, Elizabeth J., Champlin, Richard E., Mahadeo, Kris M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891040/
https://www.ncbi.nlm.nih.gov/pubmed/33614514
http://dx.doi.org/10.3389/fonc.2021.625707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891040/
https://www.ncbi.nlm.nih.gov/pubmed/33614514
http://dx.doi.org/10.3389/fonc.2021.625707

Ejemplares similares